Irish scientific and medical solutions partner Lennox has announced a deal to buy Focus Scientific Solutions, the Meath-based laboratory equipment specialists.
Lennox said the deal will support the creation of 30 high-level roles over the next two years and will see the company become the largest independent Irish company in this sector.
Founded in Dublin in 1923, Lennox employs 50 people across its sites in Dublin and Cork.
Focus Scientific Solutions, founded in 2007, is situated in Stamullen in Co Meath and employs 14 people.
Lennox CEO Leslie Brett said today's announcement represents a new phase for Lennox, building on its 100-year history.
"Over the last five years, we have prioritised investment in systems, training and logistics and have transformed the company into a tailored end-to-end solutions provider.
"Eight of the new roles announced today will be fulfilled in the next six months, across engineering, business analysis and ecommerce," Ms Brett said.
"There has been a lot of movement in our sector in recent years, with indigenous companies being acquired by outside investment. Our strategy is to grow independently," Ms Brett stated.
"Focus Scientific Solutions is the first step in this strategy, allowing us to further enhance the technical service business, target new customers and expand our product portfolio," she added.
Liam Coughlan, director of Sales & Marketing and co-founder of Focus Scientific Solutions, said there is significant scalable potential in this strategic investment.
"We look forward to the opportunities, shared learnings and combined expertise that joining Lennox will bring to our customers. Focus Scientific has a very capable and experienced team who have partnered with some of the leading global instrument manufacturers in the sector to combine their technical expertise with our own," he added.
Mike O'Connor, director of Technical Sales and Service and co-founder of Focus Scientific Solutions, said the company provides advanced technical services and solutions working with Ireland's leading biopharma, pharmaceutical and life sciences companies.
"This acquisition will allow our combined resources to expand and bring this to an even higher level. Lennox's ethos, expertise and experience will ensure we continue to deliver the highest level of personalised service," he added.
